Institutional Only|Drovix does not deal with individual investors and does not accept deposits or provide retail trading services.

Drovix.
Three nested concentric rings — capital, risk, and balance-sheet layers
Education

The Balance-Sheet Cost of Leverage: What Funding Stress Tells You About Your Counterparty

Leverage is not free, and the funding-stress component of its cost is paid by your counterparty even when nothing visibly bad has happened to you. A counterparty that does not understand its own funding curve is a counterparty whose spread will move on you for reasons you cannot diagnose.

HomeResourcesInsights & News
18 May 2026Drovix Research Desk7 min

There is a quiet line in every institutional FX broker's P&L that no marketing deck mentions: the funding cost of the inventory they are carrying for you. It is paid in basis points per day, it varies with the broker's own balance-sheet position, and on the days the broker's funding curve moves, your spread moves — for reasons that have nothing to do with your trade and everything to do with the broker's overnight repo desk.

Understanding the structure of that cost is the difference between a counterparty relationship that is durable through a stress cycle and one that quietly degrades the first time conditions tighten.

Three nested concentric rings — capital, risk, and balance-sheet layers
Three nested concentric rings — capital, risk, and balance-sheet layers

Where the cost comes from

When you take liquidity from a broker, the broker either internalises the position into its existing inventory or externalises it via a hedge to a wholesale counterparty. The internalised portion sits on the broker's balance sheet and costs the broker funding — overnight, term, and through any unscheduled events that require additional margin against that position.

The funding cost is real and is paid in two ways: an explicit interest cost (the broker is borrowing to fund the position, either via repo against collateral or via unsecured funding lines) and an implicit capital cost (the position consumes regulatory capital, which has an opportunity cost relative to its alternative deployment).

On a calm Tuesday with abundant funding liquidity and stable rates, the cost is a small known number. On a Wednesday after a hawkish central-bank surprise, the cost rises across the entire industry simultaneously, and brokers' streaming spreads widen in lockstep. Most desks experience this as 'spreads widened today' without ever connecting it to the underlying funding-curve shift.

The three components of funding cost

Overnight

The base case. The broker funds the position overnight in repo against the position itself or in unsecured funding from its treasury. The cost is the overnight rate plus the broker's spread to that rate. For a tier-1 institutional broker the unsecured spread is typically 5-20 bps; for a leveraged-broker model financed via term repo it can be 50-150 bps. Both numbers are floors, not ceilings.

Term

Positions held beyond overnight need term funding, which the broker procures in 1-week to 3-month repo or via the unsecured CP/CD market. The term curve is upward-sloping in normal conditions and inverts in funding stress; an inverted curve is one of the strongest leading indicators that broker spreads are about to widen materially.

Stress

On days when the funding market itself is dislocated — repo specials, CCP margin calls, dealer-balance-sheet constraints around quarter-end — the funding cost spikes by an order of magnitude beyond its normal level. The broker that has not pre-positioned for this experience tightens its spread in real time; the broker that has pre-positioned widens by less.

Stack of horizontal bars of decreasing length — balance-sheet capacity
Stack of horizontal bars of decreasing length — balance-sheet capacity

How this manifests as spread

Brokers that are funding-sensitive widen their spreads on the entire book during a funding-stress day, even on instruments where the underlying market is calm. This is the mechanical answer to the question 'why did my major-pair spread widen today even though nothing happened in the major-pair market'.

Brokers that are funding-resilient — well-capitalised, multi-source funded, with longer-dated funding to match their position lifetimes — widen by less and on a narrower subset of instruments. The differential is observable. A desk that tracks its own historical spread paid to each broker against a public funding-stress index (the FRA-OIS basis, the IOR-RRP differential, dealer CDS spreads) can quantify each broker's funding sensitivity within a quarter of trading data.

What to ask your counterparty

  • What is the average overnight funding cost embedded in your streaming spread on major pairs? A counterparty that cannot answer this is either uninformed about its own cost or unwilling to disclose it; both are signals.
  • What proportion of your funding is overnight versus term? An overnight-dominated funding stack widens more during funding stress; a term-dominated stack is more stable but charges a higher base.
  • Do you pre-position term funding against expected residual inventory, or do you fund it overnight by default? The answer to this question maps directly to the spread behaviour you will see during quarter-end and year-end.
  • What is your unsecured funding spread to the relevant overnight reference rate? Tier-1 institutional brokers are at 5-20 bps; anything materially wider is information about counterparty risk.

Drovix's funding profile

Drovix funds its institutional book through a mix of overnight secured repo against position collateral and term unsecured lines from a panel of tier-1 banks. The mix is approximately 30/70 overnight/term, deliberately weighted toward term to reduce the funding-stress sensitivity of the streaming book. The unsecured spread is publishable on request; the term tenor distribution is publishable on request.

The architecture that allows us to internalise efficiently — and therefore reduce the funding cost of any given inventory level — is part of what makes the spreads we publish economically sustainable. See The Architecture of a Fair Spread for the pricing side; this post is the cost side.

None of this is unique to Drovix in principle. What is increasingly unique in practice is the willingness to discuss the funding stack explicitly with a counterparty who asks. A broker that treats its funding model as confidential is a broker who has not stress-tested its own assumptions and is going to find out alongside its counterparties whether they hold.

Where to go next

→ Institutional Onboarding and Counterparty Due Diligence — the rest of the questions worth asking a counterparty before you start sending size.

→ Correlation Under Stress — the related question of how funding stress and market stress propagate together, and what that means for a hedge's reliability.

Analyst Desk

Drovix Research Desk

Institutional Research

Drovix Research Desk publishes institutional-grade analysis covering macro events, cross-asset correlations, and execution insights for professional market participants.

Related Reads

Education

Decomposing Execution Cost: The Five Components Institutional Desks Actually Track

Next Read

Education

RFQ vs Streaming by Notional: When Each Mode Wins, and Why

Next Read

Education

Capacity Planning for Execution Strategies: When the Strategy Hits Its Own Ceiling

Next Read

Back to Insights
Drovix.

Institutional-grade liquidity, connectivity, and analytics for professional market participants worldwide.

About

  • Why Drovix
  • Regulation
  • Technology
  • Contact
  • Insights
  • Execution Policy

Legal

  • Privacy
  • Terms and Agreements
  • Client Agreement
  • Risk Disclosure

Policies

  • AML/KYC Policy
  • Cookie Policy
  • Order Execution Policy
  • Complaints Handling
  • Reverse Solicitation
  • Site map

Risk Warning: Trading leveraged products such as Forex and CFDs carries a significant level of risk and may not be appropriate for all market participants. The value of derivative instruments can fluctuate rapidly, and losses may exceed initial margin. Institutional and professional clients should ensure they fully understand the risks associated with leveraged products before engaging in any transactions. Past performance is not indicative of future results. A significant proportion of professional client accounts incur losses when trading leveraged products. Prospective clients should ensure they have sufficient expertise and resources to bear the risks of leveraged trading. You should not commit capital that you cannot afford to lose.

Important — No Investor Compensation: Important: Client funds held with Drovix (MU) Ltd are not protected by any government deposit guarantee or investor compensation scheme. The Financial Services Commission (FSC) of Mauritius does not operate an investor compensation fund.

The information on this website is intended for institutional and professional clients only. It does not constitute investment advice, a solicitation, or a recommendation to enter into any transaction. Drovix does not provide services to retail clients.

Reverse Solicitation Notice: The information and services on this website are not directed at or intended for distribution to residents or nationals of any country or jurisdiction where such distribution or use would be contrary to local law or regulation. Institutional clients access Drovix (MU) Ltd services on their own initiative. It is the responsibility of each prospective institutional client to ensure compliance with the laws and regulations of their jurisdiction of incorporation or domicile.

This information is not intended for entities or persons in countries or jurisdictions under significant sanctions, including but not limited to Afghanistan, Barbados, Belarus, Burkina Faso, Cameroon, Central African Republic, Cuba, Democratic Republic of Congo, Haiti, Iran, Libya, Mali, Mozambique, Myanmar, Nicaragua, North Korea, Russia, Senegal, Sudan, Syria, Tanzania, Venezuela, Yemen, and Zimbabwe.

All information, products, and services offered on the Drovix website are not intended for entities or persons in Australia, Belgium, Canada, France, Japan, Malaysia, Poland, Ukraine, the United Kingdom, or the United States. The information on this website does not constitute investment advice or a recommendation or a solicitation to engage in any investment activity. Drovix services are available exclusively to eligible institutional and professional clients.

© 2026 Drovix (MU) Ltd. All rights reserved.

Drovix (MU) Ltd is authorised by the Financial Services Commission (FSC) in Mauritius under Investment Dealer (Full Service Dealer) excluding Underwriting licence No. GB21026813.

The company operates under www.drovix.com and is registered at C/o SALVUS (Mauritius) Ltd, Silver Bank Tower, Ground Floor, 18 Bank Street, Cybercity, Ebene 72201 Mauritius.